Heritage Global Partners is selling state of the art, late model bioprocessing, pharmaceuticals equipment and laboratory equipment formerly operated by SwanBio Therapeutics. The auction takes place in partnership with Surplus Solutions.
Clinical-stage gene therapy company SwanBio Therapeutics specialises in the development of treatments for inherited neurological conditions. Their therapies focus on conditions related to the spinal column, including adrenomyeloneuropathy.
The online auction opens on the 11th of September and bidding closes on the 13th of September. Key assets featured in the auction include: Infors HT Multitron double stack incubator shakers, AB Sciex PA 800 Plus Biologics analysis system, Sartorius Biostat B-DCU single use bioreactor, Li-Cor Odyssey M imaging system, Akoya Biosciences Vecta Polaris, Unchained Labs UNCLE, 2021 Cytiva AKTA Avant 150 FPLC system, Bio-Rad QX-200 droplet reader, Eppendorf 5910 Ri refrigerated centrifuge, Agilent 4200 TapeStation, Qiagen QiaCube HT, PronteinSimple Jess, 2021 Molecular Devices SpectraMax iD3 microplate reader, Integra Assist Plus and much more. The assets are located in Woonsocket, Rhode Island.
Heritage Global Partners is a full-service auction firm based in California. The firm conducts up to 200 auctions annually, operating across 30 countries. Heritage Global Partners works with clients across more than 28 industry sectors, selling single assets through to complete factories and turn-key facilities.
For further information about this, or any other Heritage Global Partners auction, please visit:
